Please select your page

Press Releases

Please find below a list of all Knight press releases:

April 20, 2018

Knight Therapeutics Announces Canadian Regulatory Approval for PROBUPHINE™ for Opioid Drug Dependence

March 19, 2018

Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor

March 15, 2018

Knight Reports 2017 Fourth Quarter and Year End Results

March 13, 2018

Knight Acquires Shares Pursuant to Crescita Rights Offering

March 9, 2018

Notice of Knight Therapeutics' 2017 Fourth Quarter and Year End Results Conference Call

March 8, 2018

Knight has Less Skin in the Game with Medimetriks

February 20, 2018

Knight to Participate in Crescita Rights Offering

February 15, 2018

Knight Therapeutics and SIFI S.p.A. Announce Filing of New Drug Submission for NETILDEX in Canada™

November 9, 2017

Knight Reports Third Quarter 2017 Results

November 2, 2017

Notice of Knight Therapeutics' Third Quarter 2017 Results Conference Call

October 10, 2017

Knight Announces Changing of the Finance Guard

October 10, 2017

Knight Increases Ownership in Crescita

September 21, 2017

Knight to Present at the 16th Annual CIBC Eastern Institutional Investor Conference in Montreal

August 14, 2017

Knight Supports Crescita Trajectory

August 10, 2017

Knight Reports Second Quarter 2017 Results

August 9, 2017

Knight Supports Synergy with Third Secured Loan

August 3, 2017

Notice of Knight Therapeutics' Second Quarter 2017 Results Conference Call

June 13, 2017

Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE® in Canada for Opioid Drug Dependence

June 1, 2017

Knight to Present at the Jefferies Global Healthcare Conference in New York City

May 31, 2017

Knight to Present at the National Bank Financial Quebec Conference in Toronto

May 11, 2017

Knight Reports First Quarter 2017 Results

May 10, 2017

Knight Therapeutics Inc. announces voting results from the Annual Meeting

May 4, 2017

Notice of Knight Therapeutics' First Quarter 2017 Results Conference Call

April 25, 2017

Knight to Present at the 2017 Bloom Burton & Co. Healthcare Investor Conference in Toronto

March 28, 2017

Knight Rewarded for Doing Pro Bono

March 16, 2017

Knight Reports Fourth Quarter and Year-Ended December 31, 2016 Results

March 13, 2017

Knight Therapeutics Announces the Canadian commercialization of MOVANTIK®

March 10, 2017

Notice of Knight Therapeutics' Fourth Quarter and Year Ended December 31, 2016 Results Conference Call

February 23, 2017

Knight Therapeutics Inc. Announces Board Change

February 22, 2017

ALIMERA SCIENCES AND KNIGHT THERAPEUTICS ANNOUNCE FILING OF NEW DRUG SUBMISSION FOR ILUVIEN® IN CANADA

January 26, 2017

Knight Plants Small Seed Position In Protalix

January 13, 2017

Knight Disposes of Shares of Pediapharm Inc.

January 9, 2017

API Is Core to Knight’s Successful Investment

Buy now

You can now buy this awesome Joomla Theme directly on Themeforest for a really low price for this awesome and stunning Joomla product!

Nulla vitae elit libero, a pharetra augue. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam porta sem malesuada magna mollis euismod. Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Nulla vitae elit libero, a pharetra augue.

BUY NOW ON THEMEFOREST

×

Login

Please login using your credentials recived by email when you register.

  or   Create an account

Forgot your password? |  Forgot your username?

×

Register now


I'm a small Introtext for the Register Module, I can be set in the Backend of the Joomla WS-Register Module.



  or   Login
×